Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffman, N. R.
Right arrow Articles by Preston, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffman, N. R.
Right arrow Articles by Preston, F. S., Jr.
(Chest. 1968;53:481-486.)
© 1968 American College of Chest Physicians

Friedlander's Pneumonia

A Report of 11 Cases and Appraisal of Antibiotic Therapy

Neil R. Hoffman M.D.1 and Frank S. Preston Jr. M.D.2

1 Medical Resident, Hennepin County General Hospital
2 Instructor in Medicine, Hennepin County General Hospital, and the University of Minnesota; Director, Pulmonary Laboratory, St. Mary's Hospital

An analysis of 11 cases of Friedlander's pneumonia has been presented, and the clinical features and their relation to the radiographic and pathologic findings have been discussed. In our cases, alcoholism and debilitation appeared to be factors in the disease process. There was a high, early mortality and pneumococcal infection was often associated. The upper lobes were generally involved, the right more commonly involved than the left. Leukopenia was found in only three with parenteral streptomycin and chloramphenicol. With this therapy, our over-all mortality was 54 per cent, with most deaths occurring within the first 24 hours after admission. Recent reports from the literature indicate that other antibiotics, esepecially polymicin B, kanamycin, and colistimethate may be more effective in treating Klebsiella pneumoniae, due to its changing sensitivity pattern. Cephalothin also shows some promise in the treatment of this disease. Evidence showing that many strains of Klebsiella may be resistant to streptomycin and chloramphenicol is presented. In hopes of reducing the mortality of this disease, it seems reasonable to use kanamycin, colistimethate, cephalothin or polymixin B, as a first choice antibiotic until sensitivities are available.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by the American College of Chest Physicians.